These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26078807)

  • 21. Hydrogen sulfide and the liver.
    Mani S; Cao W; Wu L; Wang R
    Nitric Oxide; 2014 Sep; 41():62-71. PubMed ID: 24582857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of hydrogen sulfide in the progression of renal fibrosis.
    Wang Y; Xing QQ; Tu JK; Tang WB; Yuan XN; Xie YY; Wang W; Peng ZZ; Huang L; Xu H; Qin J; Xiao XC; Tao LJ; Yuan QJ
    Chin Med J (Engl); 2019 Dec; 132(23):2872-2880. PubMed ID: 31856060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrogen sulfide (H2S) attenuates uranium-induced acute nephrotoxicity through oxidative stress and inflammatory response via Nrf2-NF-κB pathways.
    Zheng J; Zhao T; Yuan Y; Hu N; Tang X
    Chem Biol Interact; 2015 Dec; 242():353-62. PubMed ID: 26523793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exogenous H2S protects H9c2 cardiac cells against high glucose-induced injury and inflammation by inhibiting the activation of the NF-κB and IL-1β pathways.
    Xu W; Chen J; Lin J; Liu D; Mo L; Pan W; Feng J; Wu W; Zheng D
    Int J Mol Med; 2015 Jan; 35(1):177-86. PubMed ID: 25412187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis.
    Xu S; Liu Z; Liu P
    Int J Cardiol; 2014 Mar; 172(2):313-7. PubMed ID: 24491853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrogen Sulfide in Diabetic Complications: Focus on Molecular Mechanisms.
    Qian LL; Liu XY; Chai Q; Wang RX
    Endocr Metab Immune Disord Drug Targets; 2018; 18(5):470-476. PubMed ID: 29701162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
    Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
    Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous hydrogen sulfide exerts proliferation/anti-apoptosis/angiogenesis/migration effects via amplifying the activation of NF-κB pathway in PLC/PRF/5 hepatoma cells.
    Zhen Y; Pan W; Hu F; Wu H; Feng J; Zhang Y; Chen J
    Int J Oncol; 2015 May; 46(5):2194-204. PubMed ID: 25738635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of hydrogen sulfide on oxidative stress and fibrosis in hepatic stellate cells.
    Fan HN; Wang HJ; Yang-Dan CR; Ren L; Wang C; Li YF; Deng Y
    Mol Med Rep; 2013 Jan; 7(1):247-53. PubMed ID: 23129058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrogen sulfide as a potent cardiovascular protective agent.
    Yu XH; Cui LB; Wu K; Zheng XL; Cayabyab FS; Chen ZW; Tang CK
    Clin Chim Acta; 2014 Nov; 437():78-87. PubMed ID: 25058799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression of p38 MAPK mediates protective effects of hydrogen sulfide on hepatic fibrosis.
    Fan HN; Wang HJ; Ren L; Ren B; Dan CR; Li YF; Hou LZ; Deng Y
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):644-52. PubMed ID: 23543448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis.
    Knipe RS; Tager AM; Liao JK
    Pharmacol Rev; 2015; 67(1):103-17. PubMed ID: 25395505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding hydrogen sulfide signaling in neonatal airway disease.
    Schiliro M; Bartman CM; Pabelick C
    Expert Rev Respir Med; 2021 Mar; 15(3):351-372. PubMed ID: 33086886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of NADPH oxidase 4-related signaling by sodium hydrosulfide attenuates myocardial fibrotic response.
    Pan LL; Liu XH; Shen YQ; Wang NZ; Xu J; Wu D; Xiong QH; Deng HY; Huang GY; Zhu YZ
    Int J Cardiol; 2013 Oct; 168(4):3770-8. PubMed ID: 23830348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrogen sulfide protected gastric epithelial cell from ischemia/reperfusion injury by Keap1 s-sulfhydration, MAPK dependent anti-apoptosis and NF-κB dependent anti-inflammation pathway.
    Guo C; Liang F; Shah Masood W; Yan X
    Eur J Pharmacol; 2014 Feb; 725():70-8. PubMed ID: 24444438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hydrogen sulfide sources on inflammation and catabolic markers on interleukin 1β-stimulated human articular chondrocytes.
    Burguera EF; Vela-Anero A; Magalhães J; Meijide-Faílde R; Blanco FJ
    Osteoarthritis Cartilage; 2014 Jul; 22(7):1026-35. PubMed ID: 24831018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-κB pathways.
    Zhang H; Sun Q; Xu T; Hong L; Fu R; Wu J; Ding J
    Mol Med Rep; 2016 Jan; 13(1):224-30. PubMed ID: 26530037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrosis and cirrhosis reversibility - molecular mechanisms.
    Gieling RG; Burt AD; Mann DA
    Clin Liver Dis; 2008 Nov; 12(4):915-37, xi. PubMed ID: 18984474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using hydrogen sulfide to design and develop drugs.
    Calderone V; Martelli A; Testai L; Citi V; Breschi MC
    Expert Opin Drug Discov; 2016; 11(2):163-75. PubMed ID: 26593865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A perspective on anti-CCN2 therapy for chronic kidney disease.
    Falke LL; Goldschmeding R; Nguyen TQ
    Nephrol Dial Transplant; 2014 Feb; 29 Suppl 1():i30-i37. PubMed ID: 24493868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.